21st Austria weekly - Marinomed, AT&S (24/09/2024)

Marinomed: Marinomed Biotech AG reported positive clinical data for the new moisturizing Carragelose-containing eye drops.  The results of the study show that treatment with Carragelose eye drops for four weeks significantly improves dry eye-related symptoms by 54%. Next to excellent tolerability, patients also reported a significant improvement in Ocular Surface. The eye drops are part of the recent Carragelose portfolio expansion from viral respiratory infections to targeting allergy and dry eyes. The clinical study conducted in Spain investigated for the first time the lubricating and hydrating effectiveness of Carragelose eye drops in patients affected by mild to moderate dry eye syndrome. 28 Patients were exposed to adverse environmental conditions (23°C, 10% relative humidity and airflow) to challenge dry eye symptoms. Treatment was started after the first challenge and lasted 28 days with a dose of one drop per eye, three times daily. After this treatment period, the patients were again exposed to adverse conditions and the effectiveness of the eye drops were assessed compared to the first challenge. The primary endpoint of the study was the improvement of dry eye-related symptoms such as foreign body sensation, burning or stinging, itching, pain, sticky feeling, sensitivity to light or blurred vision.
Marinomed Biotech: weekly performance: 6.76%

AT&S: AT&S CEO Andreas Gerstenmayer reached an agreement with the Nomination Committee to step down from the AT&S AG Executive Board on September 30, 2024. AT&S is a globally leading manufacturer of high-end IC substrates and printed circuit boards.
AT&S: weekly performance: 0.50%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (24/09/2024)

Christian Drastil: Wiener Börse Plausch

SportWoche Podcast #128: Real Madrid vor Manchester City und FC Barcelona sind die wertvollsten Fussballclubs nach Markenwert

Bildnachweis

1. Team Bulle: Johannes Pracher https://audio-cd.at/page/podcast/5571   >> Öffnen auf photaq.com

Aktien auf dem Radar:Immofinanz, Porr, S Immo, Addiko Bank, Austriacard Holdings AG, Flughafen Wien, voestalpine, ams-Osram, Rosgix, Lenzing, Mayr-Melnhof, ATX, ATX TR, Frequentis, Verbund, Erste Group, EVN, DO&CO, Polytec Group, CA Immo, Cleen Energy, Pierer Mobility, SBO, UBM, EuroTeleSites AG, Oberbank AG Stamm, Agrana, Amag, OMV, Österreichische Post, Telekom Austria.

Random Partner

---

Strabag
Strabag SE ist ein europäischer Technologiekonzern für Baudienstleistungen. Das Angebot umfasst sämtliche Bereiche der Bauindustrie und deckt die gesamte Bauwertschöpfungskette ab. Durch das Engagement der knapp 72.000 MitarbeiterInnen erwirtschaftet das Unternehmen jährlich eine Leistung von rund 14 Mrd. Euro (Stand 06/17).

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner